Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC‐TFR Study

ABSTRACT Background While tyrosine kinase inhibitor (TKI) discontinuation is an established therapeutic goal, up to 60% of patients relapse after the first attempt. The feasibility of a second or third attempt at TKI discontinuation remains uncertain. Immune surveillance, particularly T‐cell and nat...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Hiroshi Ureshino, Yukio Nakamura, Yemima Budirahardja, Iwao Nozawa, Keisuke Kidoguchi, Kazuharu Kamachi, Shinya Kimura
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-08-01
Serie:	Cancer Medicine
Soggetti:	T‐cell immunology T‐cell receptor repertoire treatment‐free remission tyrosine kinase inhibitorchronic myeloid leukemia
Accesso online:	https://doi.org/10.1002/cam4.71142
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!